Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Libidup is an Ayurvedic nutritional supplement developed by MMC Healthcare (MMC Pharmaceuticals) specifically for male reproductive and sexual health. It is formulated as an oral capsule containing a blend of active ingredients including L-arginine, Tribulus terrestris, zinc, Ginkgo biloba, Mucuna pruriens, and Yohimbe bark extract. The product acts as a natural aphrodisiac and libido booster, intended to improve sexual drive, performance, and erectile function. Its mechanism of action involves supporting vascular health and blood flow (via L-arginine and Ginkgo biloba), modulating neurotransmitters (via Mucuna pruriens), and providing essential minerals like zinc for reproductive health. It is currently marketed in India as a health supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Libidup.